Israeli drug maker Teva Pharmaceutical Industries Ltd. is buying La Jolla-based Auspex Pharmaceuticals Inc. in a deal valued at about $3.2 billion, increasing Teva’s presence among treatments for central nervous system disorders, the Wall Street Journal reports.